𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Therapeutic effects of alendronate 35 mg once weekly and 5 mg once daily in Japanese patients with osteoporosis: a double-blind, randomized study

✍ Scribed by Shinji Uchida; Tadaaki Taniguchi; Takafumi Shimizu; Taro Kakikawa; Kotoba Okuyama; Masahiko Okaniwa; Hironori Arizono; Koichi Nagata; Arthur C. Santora; Masataka Shiraki; Masao Fukunaga; Tatsushi Tomomitsu; Yasuo Ohashi; Toshitaka Nakamura


Publisher
Springer
Year
2005
Tongue
English
Weight
721 KB
Volume
23
Category
Article
ISSN
0914-8779

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Efficacy and safety of a once-yearly i.v
✍ Eric S Orwoll; Paul D Miller; Jonathan D Adachi; Jacques Brown; Robert A Adler; πŸ“‚ Article πŸ“… 2010 πŸ› American Society for Bone and Mineral Research 🌐 English βš– 216 KB

## Abstract Zoledronic acid (ZOL) has shown beneficial effects on bone turnover and bone mineral density (BMD) in postmenopausal osteoporosis. This study compared the efficacy and safety of a once‐yearly i.v. infusion of ZOL with weekly oral alendronate (ALN) in men with osteoporosis. In this multi

Once-weekly administration of 50 mg etan
✍ Edward C. Keystone; Michael H. Schiff; Joel M. Kremer; Shelly Kafka; Michael Lov πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 112 KB πŸ‘ 2 views

## Abstract ## Objective To evaluate the safety, efficacy, and pharmacokinetics of 50 mg etanercept administered subcutaneously once weekly in adult patients with active rheumatoid arthritis (RA). ## Methods Four hundred twenty RA patients were randomized to receive, in a blinded manner, the stu